6 F), and an increasing trend in LAT expression was observed among responders across multiple immunotherapy cohorts (Fig.
← all excerpts
Pseudogene pair-based prognostic model reveals LAT as a biomarker of immune response in head and neck squamous cell carcinoma.
1
—
—